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(p＝0.02)とMUTYH 低活性型 (p＝0.0001)の遺伝子型
がMMの生存期間に負の影響を与える因子として抽出
された.【結 論】 BER遺伝子の低活性群では,塩基
除去修復能が低下し, MMの発症に関与することが示唆
された.また,これらの遺伝子多型はMMの臨床像と関
連し, MMの進展や予後にも影響を与えることが示唆さ
れた.
34．The association of polymorphism in DNA BER
 
genes OGG1,XRCC1, APE1 and MUTYH with the
 
risk/clinical characteristics of myelodysplastic syn-
dromes (MDS)in Japanese patients
 
Batchimeg Norjmaa,? Takayuki Saitoh,?
Atsushi Iwasaki,?Yasuhiro Nitta,?Hiroshi
 
Handa?and Hirokazu Murakami?
（１ Department of Laboratory Sciences,
Gunma University Graduate School of
 
Health Sciences）
（２ Department of Hematology, Gunma
 
University Hospital）
【Background】 Base excision repair (BER) is mainly
 
responsible for the correction of small base changes of
 
DNA damage. BER pathway involved many enzymes
 
including OGG1, XRCC1, APE1 and MUTYH. The
 
single nucleotide polymorphisms of their genes have been
 
reported to relate with several cancers. The defective
 
DNA repair is associated with an increased risk of vari-
ous cancers including hematologic malignancies. How-
ever,it is unclear these polymorphisms alter the suscepti-
bility and clinical outcome of MDS patients. The aim of
 
this study is to evaluate the association of polymorphisms
 
in gene encoding four key proteins of DNA base excision
 
repair (BER):OGG1Ser326Cys, XRCC1Arg399Gln,
APE1Asp148Glu and MUTYH Gln324His with the sus-
ceptibility and clinical features of MDS.【Methods】
Our study included 106 MDS patients［median 65.3 years,
range 17.0-86.5 years;male/female 71/35;RCUD (n＝
25), RARS (n＝7), RCMD (n＝19), RAEB-1 (n＝12),
RAEB-2(n＝12),MDS-U (n＝9),and others(n＝22)］
and 192-health control group. Genetic polymorphisms
 
in BER pathway genes were examined using PCR and
 
polymerase chain reaction-restriction fragment length
 
polymorphism (PCR-RFLP) technique.【Results】
There was no significant difference in the allele and
 
genotype frequencies of BER gene polymorphisms
 
between the MDS patients and the control group. In the
 
analysis of clinical characteristics, XRCC1 Arg/Arg
 
genotype was significantly associated with lower Hb level
(8.78±2.41 g/dL vs. 10.0±2.08 g/dL, p＜0.05) and
 
higher frequency of transformation to leukemia (21.6％
vs.7％,p＜0.05). XRCC1 non-Arg/Arg genotype was
 
associated with the secondary MDS(33.3％ vs 12.7％,p＜
0.05). In addition, the frequency of blood transfusion
 
was significantly associated with OGG1 non-Ser/Ser
 
genotype (63.6％ vs 20.7％, p＜0.01). In contrast, the
 
polymorphisms in APE1 Asp148Glu and MUTYH
 
Gln324His did not have statistically significant differences
 
in the clinical features of MDS.【Conclusion】 Our
 
findings suggest that OGG1 and XRCC1 gene polymor-
phisms may be associated with the clinical features of
 
MDS in Japanese patients.
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